secwatch.observer — SEC 8-K summary
======================================

Issuer:     United Health Products, Inc. (UEEC)
CIK:        0001096938
Form:       8-K
Filed at:   2022-07-19T23:59:59+00:00
Accession:  0001477932-22-005227
Event type: regulatory
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

UHP meets with FDA on PMA; manufacturing validation needed for review completion
--------------------------------------------------------------------------------

- On July 13, 2022, UHP and its consultant met with FDA team to discuss observations from initial PMA review.
- FDA indicated validation of certain manufacturing process elements is needed to complete PMA review.
- UHP to work expeditiously with manufacturing partner in coming weeks to accomplish remaining tasks.
- No assurance that PMA application will be approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1096938/000147793222005227/0001477932-22-005227-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1096938/000147793222005227/ueec_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-22-005227

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer